AMP dealt with $50m blow from Collimate sale delay
A hold-up with the regulator in China has delayed the sale of AMP’s capital markets business with an agreement to delay the sale costing AMP over $50 million.
A hold-up with the regulator in China has delayed the sale of AMP’s capital markets business with an agreement to delay the sale costing AMP over $50 million.
Industry